• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜异性抗体可能会错误地升高或降低分化型甲状腺癌患者的甲状腺球蛋白测量值。

Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma.

作者信息

Giovanella Luca, Keller Franco, Ceriani Luca, Tozzoli Renato

机构信息

Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

出版信息

Clin Chem Lab Med. 2009;47(8):952-4. doi: 10.1515/CCLM.2009.230.

DOI:10.1515/CCLM.2009.230
PMID:19589101
Abstract

BACKGROUND

To examine the prevalence of significant interference from heterophile antibodies (HAb) in the measurement of serum thyroglobulin (Tg), we evaluated a large cohort of samples from patients with differentiated thyroid carcinoma (DTC).

METHODS

Serum Tg measurements were performed in 406 serum samples before and after incubation of each serum sample in heterophile-blocking tubes (HBT) at room temperature for 1 h. We calculated the difference between the original Tg value and the value obtained after HBT treatment. We considered any sample showing an absolute percent difference >3 SD from the mean percent difference as being affected by HAb interference.

RESULTS

We identified five patients (1%) as showing interference from HAb. Of these, three (60%) showed a false positive or falsely increased Tg concentration without any recurrence following clinical work-up; two (40%) showed a false negative or falsely reduced Tg levels, and metastases were detected in both cases by imaging procedures.

CONCLUSIONS

HAb may increase as well as reduce the measured Tg in a significant number of patients. A positive HAb interference should be suspected if Tg elevation does not fit the clinical pictures. A negative interference is a more challenging problem because increases in Tg generally occur as the first sign of recurrence of DTC. Therefore, treatment using HBT tubes of all sera referred for Tg measurement should be considered in order to prevent both unwarranted investigations or therapy, and delayed diagnosis of recurrence in patients affected by DTC.

摘要

背景

为了研究嗜异性抗体(HAb)在血清甲状腺球蛋白(Tg)检测中显著干扰的发生率,我们评估了一大组分化型甲状腺癌(DTC)患者的样本。

方法

对406份血清样本在室温下于嗜异性阻断管(HBT)中孵育1小时前后进行血清Tg检测。我们计算了原始Tg值与HBT处理后获得的值之间的差异。我们将任何显示绝对百分比差异大于平均百分比差异3个标准差的样本视为受HAb干扰影响。

结果

我们确定有5名患者(1%)显示受HAb干扰。其中,3名患者(60%)显示Tg浓度出现假阳性或假性升高,临床检查后无任何复发情况;2名患者(40%)显示Tg水平出现假阴性或假性降低,且这两例通过影像学检查均检测到转移灶。

结论

在相当数量的患者中,HAb可能会使检测到的Tg升高或降低。如果Tg升高与临床表现不符,则应怀疑存在阳性HAb干扰。阴性干扰是一个更具挑战性的问题,因为Tg升高通常是DTC复发的首个迹象。因此,为了避免不必要的检查或治疗以及DTC患者复发的延迟诊断,对于所有送检进行Tg检测的血清,应考虑使用HBT管进行处理。

相似文献

1
Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma.嗜异性抗体可能会错误地升高或降低分化型甲状腺癌患者的甲状腺球蛋白测量值。
Clin Chem Lab Med. 2009;47(8):952-4. doi: 10.1515/CCLM.2009.230.
2
Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays.试管中的“幽灵”:血清甲状腺球蛋白检测中的嗜异性抗体干扰
J Clin Endocrinol Metab. 2003 Jul;88(7):3069-74. doi: 10.1210/jc.2003-030122.
3
Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients.异嗜性抗体很少影响分化型甲状腺癌患者的甲状腺球蛋白和甲状腺球蛋白抗体的测定。
Horm Metab Res. 2010 Sep;42(10):736-9. doi: 10.1055/s-0030-1254132. Epub 2010 May 19.
4
Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma.通过定量甲状腺球蛋白抗体测量进行甲状腺球蛋白(Tg)回收测试,以确定分化型甲状腺癌血清Tg检测中的干扰情况。
Clin Chem. 2006 Jun;52(6):1196-9. doi: 10.1373/clinchem.2005.060103. Epub 2006 Mar 30.
5
Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.未刺激状态下的高敏甲状腺球蛋白测量可预测分化型甲状腺癌的预后。
Clin Chem Lab Med. 2009;47(8):1001-4. doi: 10.1515/CCLM.2009.216.
6
The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.在存在循环抗甲状腺球蛋白(Tg)抗体的情况下,颈部淋巴结细针穿刺活检冲洗液中Tg测量对分化型甲状腺癌转移灶的诊断价值依然存在。
J Clin Endocrinol Metab. 2006 Apr;91(4):1364-9. doi: 10.1210/jc.2005-1705. Epub 2006 Jan 24.
7
Spurious increase in serum chromogranin A: the role of heterophilic antibodies.血清嗜异性抗体导致的 chromogranin A 假性升高。
Clin Chem Lab Med. 2010 Oct;48(10):1497-9. doi: 10.1515/CCLM.2010.293. Epub 2010 Jul 29.
8
Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.高敏血清甲状腺球蛋白及循环甲状腺球蛋白mRNA评估在分化型甲状腺癌临床缓解患者管理中的应用
J Clin Endocrinol Metab. 2002 Jul;87(7):3201-8. doi: 10.1210/jcem.87.7.8653.
9
Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.评估首次甲状腺球蛋白测定在分化型甲状腺癌术后转移灶检测中的诊断价值。
Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):485-9. doi: 10.1055/s-2006-951778.
10
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.在全甲状腺切除和放射性碘消融治疗后甲状腺癌分化型患者中,抗甲状腺球蛋白抗体阳性且甲状腺功能正常的患者随访期间血清促甲状腺激素升高时,诊断性全身扫描和血清甲状腺球蛋白的价值。
Thyroid. 2012 Feb;22(2):113-6. doi: 10.1089/thy.2011.0020. Epub 2012 Jan 6.

引用本文的文献

1
Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer.甲状腺球蛋白在甲状腺癌中的诊断、诊疗一体化及预后价值
J Clin Med. 2024 Apr 23;13(9):2463. doi: 10.3390/jcm13092463.
2
False diagnosis of recurrent thyroid carcinoma: the importance of testing for heterophile antibodies.假阳性诊断复发性甲状腺癌:检测嗜异性抗体的重要性。
Arch Endocrinol Metab. 2024 Mar 7;68:e230115. doi: 10.20945/2359-4292-2023-0115.
3
Thyroglobulin Assay Interferences: Clinical Usefulness of Mass-Spectrometry Methods.甲状腺球蛋白检测干扰:质谱法的临床应用价值
J Endocr Soc. 2022 Nov 2;7(1):bvac169. doi: 10.1210/jendso/bvac169. eCollection 2022 Nov 17.
4
The role of Tg kinetics in predicting 2-[F]-FDG PET/CT results and overall survival in patients affected by differentiated thyroid carcinoma with detectable Tg and negative 131I-scan.Tg 动力学在预测 2-[F]-FDG PET/CT 结果和伴有可检测 Tg 且 131I 扫描阴性的分化型甲状腺癌患者总生存中的作用。
Endocrine. 2021 Nov;74(2):332-339. doi: 10.1007/s12020-021-02755-5. Epub 2021 May 20.
5
Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study.分化型甲状腺癌患者及抗甲状腺球蛋白抗体水平升高患者的临床结局:一项回顾性研究。
Thyroid Res. 2021 Apr 15;14(1):8. doi: 10.1186/s13044-021-00099-w.
6
Iodine, thyroglobulin and thyroid gland.碘、甲状腺球蛋白和甲状腺。
Physiol Res. 2020 Sep 30;69(Suppl 2):S225-S236. doi: 10.33549/physiolres.934514.
7
Comparison between a new thyroglobulin assay with the well-established Beckman Access immunoassay: A preliminary report.新甲状腺球蛋白检测方法与贝克曼 Access 免疫检测方法的比较:初步报告。
J Clin Lab Anal. 2021 Feb;35(2):e23589. doi: 10.1002/jcla.23589. Epub 2020 Sep 20.
8
Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma.甲状腺球蛋白倍增时间比甲状腺球蛋白水平更能为非碘难治性分化型甲状腺癌患者选择进行定位[F]FDG PET/CT 的最佳候选者提供一个更好的阈值。
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):461-468. doi: 10.1007/s00259-020-04992-8. Epub 2020 Aug 13.
9
Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer.血清中期因子作为动态预后因素在监测甲状腺乳头状癌疾病状态中的变化
Medicine (Baltimore). 2018 Sep;97(36):e12242. doi: 10.1097/MD.0000000000012242.
10
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.